Panong, Rolando .
HRN: 26-72-74 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/15/2025
09/22/2025
IV
2.25g
Q6h
Perforated Peptic Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes